Objective: This study aimed to assess the association between ultraprocessed foods (UPF) consumption, eating disorders (EDs), food addiction and body image concerns.
Design: Systematic review following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.
Data Sources: Medline, Scopus, Web of Science, EMBASE, LILACS and APA PsycInfo databases, for studies published between 2009 and July 2024.
Eligibility Criteria: We included cross-sectional and cohort studies involving individuals of all ages, evaluating the association between UPF consumption, classified by the 'NOVA system', EDs, food addiction and body image. No restrictions were placed on diagnostic criteria, age and gender. Studies that modelled UPF consumption as both an exposure and an outcome were included.
Data Extraction And Synthesis: Data extraction and quality assessment were performed by two independent reviewers. Methodological quality was assessed using the Joanna Briggs Institute critical appraisal checklist.
Results: We did not identify any longitudinal studies. Nine cross-sectional studies were included (n=54 367 participants). One study assessed EDs types, including restrictive, bulimic, binge eating and other (not otherwise specified); three studies examined body dissatisfaction, while five studies investigated food addiction. The consumption of UPF was significantly associated with bulimic, binge eating and other ED and food addiction. No significant associations were identified between restrictive ED and body dissatisfaction.
Conclusion: This systematic review highlights a significant gap in research on this topic. Although some associations have been found, the findings are limited to cross-sectional studies with methodological limitations. The lack of longitudinal studies emphasises the need for more rigorous research to accurately assess the direction of these relationships.
Prospero Registration Number: CRD42022365154.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11664383 | PMC |
| http://dx.doi.org/10.1136/bmjopen-2024-091223 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The prevalence of food addiction and its association with type 2 diabetes: a systematic review with meta-analysis.
Br J Nutr
January 2025
Laboratório de Nutrição e Metabolismo, Faculdade de Nutrição, Universidade Federal de Alagoas, Maceió, Brazil.
To determine the prevalence of FA in individuals with type 2 diabetes and to assess the association between FA and type 2 diabetes. MEDLINE, EMBASE, Web of Sciences, Latin American and Caribbean Literature in Health Sciences, ScienceDirect, Scopus, and PsycINFO were searched until November 2024. This study was registered with PROSPERO (CRD42023465903).
View Article and Find Full Text PDFAccess to high-fat diet results in increased sensitivity to the psychostimulant effects of MDPV in mice.
Pharmacol Rep
January 2025
Research Laboratory CoreLab of the Medical University of Lodz, Łódź, Poland.
Background: The current study investigated the effects of high-fat diet on acute response to 3,4-methylenedioxypyrovalerone (MDPV) in mice. MDPV is a beta-cathinone derivative endowed with psychostimulant activity. Similarly to recreational substances, consumption of palatable food stimulates the mesolimbic dopaminergic system, resulting in neuroadaptive changes.
View Article and Find Full Text PDFBinge eating behaviours are associated with recurrent weight gain after metabolic and bariatric surgery.
Clin Obes
January 2025
Department of Internal Medicine, Division of Endocrinology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Background: Recurrent weight gain (RWG) is a major post-operative challenge among metabolic and bariatric surgery (MBS) patients. Binge eating behaviours (BEB) and food addiction (FA) have been identified as significant predictors of post-MBS RWG. However, limited research has investigated their independent associations with post-MBS RWG.
View Article and Find Full Text PDFAdvanced Pain Management in Patients with Terminal Cancer.
Curr Med Chem
January 2025
Department of Surgery, School of Medicine, Nazarbayev University, 5/1 Kerey and Zhanibek khandar str., 020000, Astana, Kazakhstan.
Understanding and managing pain in patients with terminal cancer is a vital aspect of palliative care, aimed at relieving suffering and improving quality of life in the final stages of illness. Studies indicate that approximately 50% of patients with stage 4 cancer report moderate to severe pain, with a quarter experiencing severe cancer-related pain. Despite opioid prescriptions in 97% of cases, a significant portion of patients continues to suffer unresolved pain during the last week of life.
View Article and Find Full Text PDFOpioid reward and deep brain stimulation of the lateral hypothalamic area.
Vitam Horm
January 2025
Department of Physiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. Electronic address:
Opioid use disorder (OUD) is considered a global health issue that affects various aspects of patients' lives and poses a considerable burden on society. Due to the high prevalence of remissions and relapses, novel therapeutic approaches are required to manage OUD. Deep brain stimulation (DBS) is one of the most promising clinical breakthroughs in translational neuroscience.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!